Area of research
Oncology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Cancer survivorship and care, Palliative Care and End-of-Life Issues, Childhood Cancer Survivors' Quality of Life, and Cancer-related cognitive impairment studies.
Complex Interventions in Health
Patients' symptoms and challenges during the first year after allogeneic haematopoietic cell transplantation-patients' own expressions.
Understanding Physical Activity in Patients With Metastatic Breast Cancer: An Analysis Rooted in the Theory of Planned Behaviour.
Introduction to Section III
Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial
Impact of exercise on sexual health, body image, and therapy‐related symptoms in women with metastatic breast cancer: The randomized controlled <scp>PREFERABLE</scp>‐<scp>EFFECT</scp> trial
Considerations for delivery of live-remote exercise for people with cancer in research and practice
Influence of endoxifen on mammographic density: results from the KARISMA-Tam trial.
Impact of exercise on sexual health, body image, and therapy-related symptoms in women with metastatic breast cancer: The randomized controlled PREFERABLE-EFFECT trial.
Factors Associated With Employment and Quality of Working Life in Patients With Metastatic Breast Cancer.
Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial
Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial.
Five-year follow-up of the OptiTrain trial on concurrent resistance and high-intensity interval training during chemotherapy for patients with breast cancer
Metastatic breast cancer patients’ preferences for exercise programs: a latent class analysis using data from a survey in five European countries
Cost-utility analysis of a supervised exercise program for patients with metastatic breast cancer in the PREFERABLE-EFFECT randomized controlled trial (RCT).
Abstract GS02-10: Effects of a structured and individualized exercise program on fatigue and health-related quality of life in patients with metastatic breast cancer: the multinational randomized controlled PREFERABLE-EFFECT study
EUSOMA quality indicators for non-metastatic breast cancer: An update
Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women
International development of a patient-centered core outcome set for assessing health-related quality of life in metastatic breast cancer patients
PERSPECTIVEs on supervised exercise programs in people with metastatic breast cancer- a qualitative study in four European countries
Perspectives of patients with metastatic breast cancer on physical exercise programs: results from a survey in five European countries
PERSPECTIVEs on supervised exercise programs in people with metastatic breast cancer- a qualitative study in four European countries.
Perspectives of patients with metastatic breast cancer on physical exercise programs: results from a survey in five European countries.
Early Detection of Brain Metastases in a Supervised Exercise Program for Patients with Advanced Breast Cancer: A Case Report
Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial
Design of a multinational randomized controlled trial to assess the effects of structured and individualized exercise in patients with metastatic breast cancer on fatigue and quality of life: the EFFECT study
Worry about getting infected, confidence in safeguards, and received treatment between waves one and two of COVID-19 among patients with cancer in the Stockholm region
Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial
ESO–ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)
Reduced symptom burden with the support of an interactive app during neoadjuvant chemotherapy for breast cancer – A randomized controlled trial